China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Safety and Efficacy of High-Dose ¹⁷⁷Lu-PSMA versus ²²⁵Ac-PSMA for the Treatment of ¹⁷⁷Lu-Refractory Prostate Cancer: A Phase II Clinical Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131867
Registration Time: 2026/09/07
Type: Interventional study
Primary Sponsor: The Affiliated Hospital of Southwest Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342029
Published by HT Digital Content Services with permission from Health Daily Digest....